Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket

Published 02/12/2022, 12:49
Updated 02/12/2022, 14:10
© Reuters.  Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket

© Reuters. Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket

Benzinga - Gainers

  • Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares rose 44.7% to $0.9902 in pre-market trading after the company reported the U.S. FDA approval of REZLIDHIA (olutasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.
  • MEI Pharma, Inc. (NASDAQ: MEIP) shares rose 22.2% to $0.40 in pre-market trading. The company, last month, posted a narrower quarterly loss.
  • Ra Medical Systems, Inc. (NYSE: RMED) rose 17.7% to $3.73 in pre-market trading after jumping 29% on Thursday. Ra Medical Systems, last month, posted a Q3 loss of $4.36 per share.
  • Helbiz, Inc. (NASDAQ: HLBZ) rose 13.3% to $0.2450 in pre-market trading. Helbiz Kitchen, a part of Helbiz, partnered to bring food delivery to United States with Kitchen United.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) rose 12.4% to $1.63 in pre-market trading after dropping 7% on Thursday.
  • Top Ships Inc. (NASDAQ: TOPS) rose 11.8% to $4.06 in pre-market trading after jumping 20% on Thursday.
  • Exela Technologies, Inc. (NASDAQ: XELA) shares rose 10.7% to $0.1959 in pre-market trading. Exela Technologies, last month, reported worse-than-expected Q3 sales results.
  • Yunhong CTI Ltd. (NASDAQ: CTIB) rose 10.5% to $0.42 in pre-market trading after dipping 56% on Thursday.
  • Sensus Healthcare, Inc. (NASDAQ: SRTS) rose 10.4% to $7.34 in pre-market trading. Sensus Healthcare, last month, reported worse-than-expected Q3 EPS and sales results..
  • CEVA, Inc. (NASDAQ: CEVA) rose 9.8% to $30.64 in pre-market trading. CEVA, last month, reported worse-than-expected Q3 sales results.
  • Achilles Therapeutics plc (NASDAQ: ACHL) rose 8.7% to $1.90 in pre-market trading after dropping 13% on Thursday.
  • CarLotz, Inc. (NASDAQ: LOTZ) rose 7.7% to $0.1799 in pre-market trading. The company, last month, posted a wider quarterly loss.
  • UiPath Inc. (NYSE: PATH) rose 7.6% to $13.90 in pre-market trading after the company reported upbeat Q3 results and issued strong sales forecast.
  • RPC, Inc. (NYSE: RES) gained 7.1% to $9.67 in pre-market trading.
Don’t forget to check out our premarket coverage here .

Losers

  • Asana, Inc. (NYSE: ASAN) fell 19.3% to $14.60 in pre-market trading after the company reported upbeat third-quarter financial results, but issued soft guidance.
  • Biophytis S.A. (NASDAQ: BPTS) shares fell 15.5% to $0.4216 in pre-market trading after declining over 25% on Thursday.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) fell 13.7% to $0.3150 in pre-market trading after the company reported a proposed public offering.
  • ObsEva SA (NASDAQ: OBSV) shares fell 11.4% to $0.1880 in pre-market trading after posting a wider-than-expected Q3 loss.
  • Otonomy, Inc. (NASDAQ: OTIC) fell 11% to $0.1450 in pre-market trading after dropping 9% on Thursday.
  • Sonim Technologies, Inc. (NASDAQ: SONM) fell 9.7% to $0.4814 in pre-market trading. Sonim Technologies shares jumped 29% on Thursday after the company announced a $17 million additional tablet order.
  • Zscaler, Inc. (NASDAQ: ZS) shares fell 8.4% to $132.17 in pre-market trading after the company reported first-quarter results.
  • Marvell Technology, Inc. (NASDAQ: MRVL) fell 6.9% to $42.26 in pre-market trading after the company reported weaker-than-expected results for its third quarter and issued weak forecast for the current quarter.
  • Mullen Automotive, Inc. (NASDAQ: MULN) shares fell 5.8% to $0.2047 in pre-market trading. Mullen Automotive shares gained 13% on Thursday after the company announced it closed on the acquisition of Electric Last Mile Solutions' assets.
  • Veeva Systems Inc. (NYSE: VEEV) fell 4.9% to $182.10 in pre-market trading. Veeva posted upbeat results for its third quarter, but issued weak guidance for the fourth quarter.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.